A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities (NCT05671380)
🩺 Plain-English Summary (8th-Grade Level)
This project will evaluate a proactive outreach intervention for tobacco cessation among primary care BIPOC populations who smoke in two health systems across the region. Compared with Whites, BIPOC populations in the US experience disproportionate health consequences from commercial cigarette use. Few evidence-based cessation treatments (EBCTs) have been specifically developed, evaluated, or implemented for BIPOC populations. Moreover, uptake of EBCT (e.g. medication, counseling) is lower among BIPOC populations. Reasons for the failure to engage BIPOC patients in EBCTs are complex and multi-level (e.g., patient, provider, healthcare system). To address these gaps, the investigators will assess the added effectiveness of an approach to augment the standard of care with longitudinal proactive outreach to connect BIPOC adults with EBCT. The proposed multi-level intervention leverages the electronic health record to identify patients who smoke, who can then be proactively engaged via culturally tailored outreach to connect them to EBCT. The proactive approach may circumvent experiences of bias within the healthcare system and thus enhance engagement.
Who can join: Review the eligibility criteria below.
Location: Hennepin Healthcare — Minneapolis, Minnesota
Age range: 18 Years
🧪 Interventions in This Study
- Longitudinal Proactive Outreach (LPO). (BEHAVIORAL)
- Ask-Advice-Connect (AAC) (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Hennepin Healthcare — Minneapolis, Minnesota
- University of Minnesota — Minneapolis, Minnesota
- Mayo Clinic Health System — Rochester, Minnesota
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Tobacco Use Cessation
- Ask Advise Connect (AAC) Harris Heath CPRIT — Houston, Texas
- Cessation Clinical Trial — Washington D.C., District of Columbia
- Reward Sensitivity and Pharmacotherapy for Smoking Cessation — Houston, Texas
- Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion) — Chicago, Illinois
- Feasibility of Delivering VergeRx at FQHCs — Charlottesville, Virginia
Explore by condition: All Tobacco Use Cessation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.